Tag: OTC:LXRP

March 23, 2020

Lexaria Bioscience Expands Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment

Lexaria Bioscience has expanded the scope and activities of its 100%-owned subsidiary Lexaria Pharmaceutical Corp.
March 19, 2020

Lexaria Bioscience Begins Coronavirus COVID-19 Drug Delivery Program

Lexaria Bioscience is commencing a program to study the benefits of Lexaria's DehydraTECHTM drug delivery platform in the fight against...
March 17, 2020

Lexaria Bioscience Announces Warrant Issuance

Lexaria Bioscience Corp. announces that on March 16, 2020 it issued share purchase warrants to one of its Canadian-based consultants.
March 5, 2020

Lexaria Provides Update on Two Licensed Clients

Lexaria Bioscience has successfully processed its first DehydraTECHTM-enabled liquid nanoemulsion for CBD beverages for one of its licensed clients.
February 13, 2020

Industry Solutions from Lexaria’s DehydraTECH(TM) Hemp and Cannabis Powders

Lexaria Bioscience Corp. announces that its DehydraTECH(TM)-enabled CBD infused powders are now available for sale across the USA.
January 22, 2020

Lexaria Bioscience Corp. and Cannadips Cannabis Announce Expanded Relationship Into Cannabis Oral Pouch & Dip Category

Lexaria announces that it has reached a new definitive agreement to provide its patented DehydraTECHTM technology to Cannadips' cannabis products.
January 14, 2020

Lexaria Biosciences and Cannadips CBD reached definitive Technology Licensing agreement for CBD Oral Pouch & Dip Category

Lexaria Bioscience Corp. announces that it has reached a definitive agreement to provide its patented DehydraTECHTM technology to Cannadips CBD.